Keros Therapeutics, Inc. (KROS) Total assets 2019–2025
Keros Therapeutics, Inc. (KROS) total assets at each fiscal year-end, per SEC filings.
$338.0MFY2025 · since FY2019: $11.0M → $338.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $338.0M | -45.1% |
| FY2024 | $615.9M | +66.4% |
| FY2023 | $370.0M | +20.6% |
| FY2022 | $306.8M | +20.2% |
| FY2021 | $255.3M | -5.3% |
| FY2020 | $269.4M | +2359.5% |
| FY2019 | $11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice